Clinical trials often involve data from thousands of participants. But, two decades ago, the enzyme replacement therapy Adagen gained US approval solely on the basis of the case history of 12 people. How did Adagen make it through the rigors of approval with so few subjects? (Click here to continue reading)

Image: Istock Photo